ABSTRACT
LISDEXAMFETAMINE Trade name: Vyvanse (Shire) Indications: Attention-deficit hyperactivity disorder (ADHD) Category: CNS stimulant; Dextroamphetamine prodrug Half-life: 1 Hour Clinically important, potentially hazardous interactions with: MAO inhibitors
